(CNN) — The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect against bird flu, the pharmaceutical company announced Friday.

"Today, we announce the beginning of an exciting new chapter for Novavax with the launch of a strategically important partnership with one of the world's leading vaccine companies," NVAX CEO John ...

Covid vaccines saved lives. Lots of them. Research by the World Health Organization (WHO) now puts the number at 475,000 in the UK with many more kept out of hospital or off a ventilator.

Novavax (NVAX) ended the recent trading session ... Coming into today, shares of the vaccine maker had lost 5.5% in the past month. In that same time, the Medical sector lost 3.48%, while the ...

Marcos Jr. expressed strong support for the continued construction of the Virology and Vaccine Institute of the Philippines (VIP) building. The Department of Science and Technology (DOST) has ...

White spots on the skin can occur with many different conditions, including eczema. Depending on the cause, treatment may include topical products and medications. White skin spots aren’t ...

Babies are supposed to receive vaccines that protect against about 15 different infectious diseases. Most require more than one dose, which amounts to nearly 30 jabs by age two. Parents may be ...

These are jabs developed by Pfizer Biontech, Moderna and AstraZeneca. While the Novavax and the Sanofi GSK vaccines will not be part of the module, it will look at the circumstances surrounding ...

As you can see from the chart above the percentage of shares that are sold short for Novavax has declined since its last report. This does not mean that the stock is going to rise in the near-term ...

The most recent mRNA vaccines, manufactured by Pfizer-BioNTech and Moderna, target the KP.2 Omicron subvariant. Novavax's updated protein-based vaccine targets the JN.1 subvariant of Omicron ...